Research Area
Treatment for Incurable diseases
new drugs for incurable diseases with high clinical/social demand
Cancer
- Major cause of death, resistance to existing treatments
- High needs for therapies to improve survival rates and quality of life
Brain Disease
- Alzheimer’s (dementia), Parkinson’s, Multiple Sclerosis
- Neurodegenerative decline, limited effectiveness of existing treatments
- Rapid increase of aging patients need to improve quality of life
Fibrotic Disease
- Pulmonary fibrosis, Renal fibrosis
- Kidney function decline, lack of treatment options
- Reduced medical costs from less dialysis and improved patient quality of life
Autoimmune Diseases
- Ulcerative colitis, Chronic kidney disease
- Organ damage due to chronic inflammation, side effect issues with existing drugs
- Deterioration of patient quality of life, urgent need for new drugs with fewer side effects
Metabolic Diseases
- Obesity
- Increased complications, rising obese population becoming a social issue, side effects of existing treatments
- Rapid increase in obesity prevalence, need for healthcare cost reduction
